Strongly increased efficiency of altered peptide ligands by mannosylation

International Immunology

Volumn 10, Issue 9, 1998, Pages 1299-1304

  Tan, M C Agnes A ^a   Jordens, Reina ^a   Geluk, Annemiek ^a   Roep, Bart O ^a   Ottenhoff, Tom ^a   Drijfhout, Jan Wouter ^a   Koning, Frits ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Altered peptide ligand; Mannosylation

Indexed keywords

ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNOSE; MANNOSE RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; HLA-DR ANTIGENS; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MANNOSE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; T-LYMPHOCYTES;

EID: 0031715652     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/10.9.1299     Document Type: Article

References (28)

1. Jameson, S. C. and Bevan, M. J. 1995. T cell receptor antagonists and partial agonists. Immunity 2:1.
2. Germain, R. N., Levine, E. H and Madrenas, J. 1995. The T-cell receptor as a diverse signal transduction machine. The Immunologist 3/4:113.
3. Evavold, B. D., Sloan-Lancaster, J. and Allen, P. M. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14:602.
4. Windhagen, A., Scholz, C., Höllsberg, P., Fukaura, H., Sette, A. and Hafler, D. A. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2:373.
5. Sloan-Lancaster, J., Evahold, B. D. and Allen, P. M. 1993 Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363:156.
6. De Magistris, M T., Alexander, J., Coggeshall, M., Altman, A., Gaeta, F. C. A., Grey, H. M. and Sette, A. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625.
7. Evavold, B. D., Sloan-Lancaster, J., Wilson, K. J., Rothbard, J. B. and Allen, P. M. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655.
8. Karin, N., Mitchell. D. J., Brocke, S., Ling, N. and Steinman, L. 1994. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of Interferon γ and tumor necrosis factor α production. J. Exp. Med. 180:2227.
9. Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B. and Kuchroo, V. K. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.
10. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U, Karin, N., Mitchell, D., Veromaa, T., Waisman, A., Gaur, A., Conlon, P., Ling, N., Fairchild, P. J., Wraigth, D. C., O'Garra, A., Fathman C. G, and Steinman. L. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
11. Lyons, D. S., Lieberman, S. A., Hampl, J., Boniface, J. J., Chien, Y.-h., Berg, L. J. and Davis, M. M. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53.
12. Ruppert, J., Alexander, J., Snoke, K., Coggeshall, Herbert, E., McKenzie, D., Grey, H. M. and Sette, A. 1993. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T cell signalling events. Proc. Natl. Acad. Sci. USA 90:2671.
13. Snoke, K., Alexander, J., Franco, A., Smith, L., Brawley, J. V., Concannon, P., Grey, H. M., Sette, A. and Wentworth, P. 1993. The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides. J. Immunol. 151:6815.
14. Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka, G. and Grey, H. M. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12: 413.
15. Lanzavecchia, A. 1990. Receptor-mediated uptake and its effect on antigen presentation to class II restricted T lymphocytes. Annu. Rev. Immunol. 8:773.
16. Watts, C. and Marsh, M. 1992. Endocytosis: what goes in and how? J. Cell Sci. 103:1.
17. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389
18. Ezekowitz, R. A., Sastry, K., Bailly, P. and Warner, A. J. 1990. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeast in Cos-1 cells. J. Exp. Med. 172:1785.
19. Jiang, W., Swiggard, W. J., Heuffler, C., Peng, M., Mirza, R. M. Steinman, R. M. and Nussenzweig, M. C. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen presentation. Nature 305:151.
20. Tan, M. C. A. A., Mommaas, A. M., Drijfhout, J. W., Jordens, R., Onderwater, J. J. M., Verwoerd, D., Mulder, A. A., Van der Heiden, A. N., Scheidegger, D., Oomen, L. C. J. M., Ottenhoff, T. H. M., Tulp, A., Neefjes, J. J. and Koning, F. 1997. Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. J. Immunol. 27: 2426.
21. Engering, A. J., Cella, M., Fluitsma, D., Brockhaus, M., Hoefsmit, E. C. M., Lanzavecchia, A. and Pieters, J. 1997. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 27:2417.
22. Gausepohl, H., Kraft, M., Boulin, C. and Frank, R. W. 1990. A multiple reaction system for automated simultaneous peptide synthesis. In Giralt, E. and Andreu, D., eds, Peptides 1990, p. 206, Escom, Leiden.
23. Geluk, A., Van Meijgaarden, K. E., Janson, A. A. M., Drijfhout, J. W., Meloen, R. H., Vries, R. R. P. de and Ottenhoff, T. H. M. 1992. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17 binding motif and enables the design of allele specific competitor peptides. J. Immunol. 149: 2864.
24. Hoogerhout, P., Donders, E. M. L. M., Gaans, J. A. M. van, Brink, B. van den, Kuipers, H. F. Brugghe, L. M. A. van Unen, H. A. M. Timmermans, G. J. ten Hove, A. P. J. M. de Jong, C. C. A. M. PeetersWiertz, E. J, H. J. and Poolman, J. T. 1995. Conjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class I outer membrane protein of Neisseria meningitidis. Infect. Immun. 63:3473.
25. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-α J. Exp. Med. 179:1109.
26. Neophytou, P. I., Roep, B. O., Arden, S. D., Muir, E. M., Duinkerken, G., Kallan, A., Vries, R. R. P. de and Hutton, J. C. 1996. T-cell epitope analysis using subtracted expression libraries (TEASEL): application to a 38-kDa autoantigen recognized by T cells from an insulin-dependent diabetic patient. Proc. Natl Acad. Sci. USA 93:2014.
27. Arden, S. A., Roep, B. O., Neophytou, P. I., Usac, E. F., Duinkerken, G., Vries, R. R. P. de and Hutton, J. C. 1996. Imogen 38, a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient. J. Clin. Invest. 97:551.
28. Geluk, A., van Meijgaarden, K. E., Southwood, S., Oseroff, C., Drijfhout, J. W., de Vries, R. R. P., Ottenhoff, T. H. M. and Sette, A. 1994. HLA-DR17(3) molecules can bind peptides carrying two alternative specific submotifs. J. Immunol. 152:5742.